PDA

View Full Version : CUT OFF YOUR NOsE TO SPITE YOUR FACE!


kahljorn
Aug 21st, 2006, 10:26 PM
Your face being gastric cancer of course! BELIEVE IT OR NOT GASTROECTOMY ALONG WITH MANY OTHER SURGERIES THAT REMOVE IMPORTANT BODILY ORGANS THAT THE BODY RELIES ON TO SURVIVE HENCE THEM BEING IN THE BODY IN THE FIRST PLACE HOW CONVENIENT ACTUALLY CAUSES YOU TO DIE YOUNGER DUE TO PROCESSING ERRORS WITHIN THE BODY.
Does it pay off in the end? IS THIS A GAMBLE WORTH TAKING? YOU SIRS WILL BE THE DECIDERS
I mean reeally HERIDITARY CANCER? There's a gene in your body that tells your cells to REPRODUCE FOR NO GOOD REASON? I've heard some doctors say that many things that are "genetic" have more to do with bad habits taught at a young age.
Hopefully I'll find out more about heridtary gastric cancer soon to insert some important opinions. However, the only decent doctor I've talked to about this had intense eyebrow raising and facially expressed shock :O

SoURCE (http://www.bccancer.bc.ca/ABCCA/NewsCentre/NewsArchive/2001BCCancerAgencyNews/20010620LocalResearchLeadstoNewTreatmentforHeredit aryGastricCancer.htm)


2001/06/20: Local Research Leads to New Treatment for Hereditary Gastric Cancer


Print this Page

BC Cancer Agency Pathologist's work featured in the New England Journal of Medicine

VANCOUVER - Dr. David Huntsman, a 35-year-old genetic pathologist working with the Hereditary Cancer Program at the BC Cancer Agency, spearheaded an international research collaboration that has led to a new approach to managing patients at extreme risk for developing gastric (stomach) cancer. His paper, entitled Early Gastric Cancer in Young Asymptomatic Carriers of Germline E-cadherin Mutations, is featured in the June 21st issue of the New England Journal of Medicine, one of the most highly regarded medical journals in the world. It is the result of collaboration between cancer researchers from the United States, Canada, the United Kingdom and Portugal

Dr. Huntsman with Dr. Caldas from the University of Cambridge is coordinating an international effort to determine why some families are especially prone to developing gastric cancer. His work at the BC Cancer Agency has demonstrated that in cases of extreme gastric cancer risk, a radical treatment option that involves the prophylactic removal of a patient's stomach may be warranted. This surgery is recommended only in cases where there is a very strong family history of gastric cancer and when the cancer risk can be proven by genetic testing.

One of the two families featured in the New England Journal of Medicine paper came from Victoria, British Columbia. Within this family multiple individuals from several generations died of gastric cancer. Two members of this family elected to have their stomachs removed (prophylactic gastrectomies) as a preventative measure against gastric cancer. These operations were performed after genetic testing demonstrated that the patients were at high risk and after careful considerations of the risks and potential benefits of the procedure. " color=#660066 size=3 FONT explains.< Huntsman Dr. unusual,? very were family this in cancers the of onset age young and history strong The>

The first surgery was performed in1993 on a 27 year-old woman whose identical twin had died of gastric cancer three years earlier. Upon examining her stomach after the surgery, it was confirmed that the cancer was present, although identifiable only through a microscope. In 1998, Dr. Huntsman and his colleagues identified the genetic abnormality responsible for the cancer susceptibility in this family and were then able to offer genetic testing to other family members to determine who carried this high risk gastric cancer gene. It was determined that one of the patient's older sisters carried the gene. After counseling with a geneticist, dietitian and surgeon, she elected to have a gastrectomy in 1999.

"I had a sleepless night before her surgery," Dr. Huntsman explains. "Here we had a healthy woman, with no symptoms or evidence of cancer, and we had recommended the removal of her stomach. You can imagine our relief when we discovered more than 50 tiny cancerous lesions throughout her stomach wall - too small to be detected through endoscopy. Her stomach was like a time bomb!"

One of the tragedies of hereditary gastric cancer is that by the time the symptoms are evident it is usually too late for the patient. Only 20% of patients with large symptomatic gastric cancers are alive five years after diagnosis. Both sisters from Victoria are living cancer-free today. "The cancers identified in these prophylactic gastrectomy cases were very tiny and therefore we believe that the patients have been cured," Dr. Huntsman continues. "It is ironic that in the five cases described in our paper, the surgical intent was the prevention of cancer. Instead of preventing it, we cured it."

The BC Cancer Agency is responsible for cancer care and research in British Columbia. The BC Cancer Agency provides a comprehensive cancer care program by working with community partners to deliver a range of oncology services, including, prevention, early detection, diagnosis and treatment, education, supportive care, rehabilitation and palliative care. Research conducted by the BC Cancer Agency into the causes and cures for cancer is supported by the BC Cancer Foundation; a non-profit organization dedicated to raising funds for cancer research in British Columbia.

The BC Cancer Agency is committed to reducing the incidence of cancer, reducing the mortality from cancer and improving the quality of life of those living with cancer. It provides a comprehensive cancer control program for the people of British Columbia by working with community partners to deliver a range of oncology services, including prevention, early detection, diagnosis and treatment, research, education, supportive care, rehabilitation and palliative care. The BC Cancer Research Centre conducts research into the causes and cures for cancer. The BC Cancer Foundation has a mandate to raise funds to support the work of the Agency and Research Centre.

For more information, please contact:
Papinder Rehncy
Public Relations
Phone: (604) 877-6098 Ext. 2378
E-mail: PRehncy@bccancer.bc.ca